跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PEMETREXED GLENMARK 500 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
PEMETREXED GLENMARK 500 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG
Approved
STANDARD
PEMETREXED GLENMARK 500 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG
Glenmark Arzneimittel Gmbh
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Mar 13, 2025
Approval ID
5a5f1883fa676d5b
Company
Glenmark Arzneimittel Gmbh
Type
Standard
Approval Details
Approval Id
5a5f1883fa676d5b
Drug Cima Aemps Name
PEMETREXED GLENMARK 500 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG
Register Number
90206
Holder Company Name
Glenmark Arzneimittel Gmbh
Marketing Company Name
Glenmark Farmaceutica S.L.U
Holder Company Detail Path
/organization/glenmark-arzneimittel-gmbh
Authorization Date
2025-03-13
Dosage Form
POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose
500 mg
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
No
Company Name
Glenmark Arzneimittel Gmbh
Company Detail Path
/organization/glenmark-arzneimittel-gmbh
Company Information
Pharmaceutical Company Name
Glenmark Arzneimittel GmbH
Country Name
Germany
Website
http://www.glenmark.de
Active Ingredients
PEMETREXED
500 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Mar 13, 2025
Approval ID
5a5f1883fa676d5b
Type
Standard
Back to CIMA-AEMPS Approvals